Gilead Sciences (GILD) Short Interest Ratio & Short Volume $110.28 0.00 (0.00%) Closing price 08/7/2025 04:00 PM EasternExtended Trading$115.18 +4.90 (+4.44%) As of 08:33 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Gilead Sciences Short Interest DataGilead Sciences (GILD) has a short interest of 22.54 million shares, representing 1.82% of the float (the number of shares available for trading by the public). This marks a 7.38% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.8, indicating that it would take 2.8 days of the average trading volume of 5.65 million shares to cover all short positions.Current Short Interest22,540,000 sharesPrevious Short Interest20,990,000 sharesChange Vs. Previous Month+7.38%Dollar Volume Sold Short$2.46 billionShort Interest Ratio2.8 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares1,243,930,000 sharesFloat Size1,240,000,000 sharesShort Percent of Float1.82%Today's Trading Volume9,177,248 sharesAverage Trading Volume5,652,979 sharesToday's Volume Vs. Average162% Short Selling Gilead Sciences? Sign up to receive the latest short interest report for Gilead Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGILD Short Interest Over TimeGILD Days to Cover Over TimeGILD Percentage of Float Shorted Over Time Gilead Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/202522,540,000 shares $2.46 billion +7.4%1.8%2.8 $109.06 6/30/202520,990,000 shares $2.33 billion -8.7%1.7%2.4 $110.87 6/15/202522,990,000 shares $2.53 billion +9.8%1.9%2.5 $109.98 5/31/202520,940,000 shares $2.31 billion -15.2%1.7%2.2 $110.35 5/15/202524,680,000 shares $2.48 billion +4.7%2.0%2.5 $100.34 4/30/202523,570,000 shares $2.51 billion +17.4%1.9%2.4 $106.54 4/15/202520,080,000 shares $2.12 billion -6.1%1.6%2.1 $105.68 3/31/202521,390,000 shares $2.40 billion -4.3%1.7%2.3 $112.05 3/15/202522,340,000 shares $2.49 billion -1.1%1.8%2.7 $111.44 2/28/202522,580,000 shares $2.58 billion +6.7%1.8%2.9 $114.31 Get the Latest News and Ratings for GILD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Gilead Sciences and its competitors with MarketBeat's FREE daily newsletter. 2/15/202521,160,000 shares $2.20 billion -7.7%1.7%3 $104.08 1/31/202522,930,000 shares $2.23 billion -8.9%1.9%3.2 $97.20 1/15/202525,170,000 shares $2.33 billion -1.9%2.0%3.6 $92.38 12/31/202425,660,000 shares $2.37 billion +16.7%2.1%4 $92.37 12/15/202421,980,000 shares $2.02 billion -6.1%1.8%3.3 $91.86 11/30/202423,410,000 shares $2.17 billion +29.6%1.9%3.4 $92.58 11/15/202418,060,000 shares $1.60 billion +1.8%1.5%2.7 $88.40 10/31/202417,740,000 shares $1.58 billion +7.7%1.4%2.8 $88.82 10/15/202416,480,000 shares $1.41 billion -7.1%1.3%2.7 $85.82 9/30/202417,740,000 shares $1.49 billion -11.1%1.4%2.7 $83.84 9/15/202419,950,000 shares $1.65 billion +0.8%1.6%3 $82.81 8/31/202419,800,000 shares $1.56 billion +18.1%1.6%2.8 $79.00 8/15/202416,770,000 shares $1.25 billion -6.0%1.4%2.3 $74.34 7/31/202417,840,000 shares $1.36 billion -16.1%1.4%2.4 $76.06 7/15/202421,250,000 shares $1.50 billion -7.6%1.7%2.8 $70.81 6/30/202423,000,000 shares $1.58 billion +22.3%1.9%3.1 $68.61 6/15/202418,810,000 shares $1.22 billion -26.0%1.5%2.5 $65.06 5/31/202425,430,000 shares $1.63 billion +17.2%2.1%3.6 $64.27 5/15/202421,700,000 shares $1.45 billion +2.6%1.8%3.2 $67.01 4/30/202421,160,000 shares $1.38 billion -0.1%N/A2.9 $65.20 4/15/202421,180,000 shares $1.43 billion -6.2%N/A2.9 $67.75 3/31/202422,570,000 shares $1.65 billion +17.3%N/A3 $73.25 3/15/202419,250,000 shares $1.42 billion -2.1%1.6%2.7 $73.69 2/29/202419,670,000 shares $1.42 billion -1.1%1.6%2.7 $72.10 2/15/202419,880,000 shares $1.46 billion +27.0%1.6%2.8 $73.37 1/31/202415,660,000 shares $1.23 billion -8.6%1.3%2.2 $78.26 1/15/202417,140,000 shares $1.48 billion +0.6%1.4%2.6 $86.38 12/31/202317,040,000 shares $1.38 billion -7.9%N/A2.7 $81.01 12/15/202318,500,000 shares $1.49 billion +6.2%N/A3 $80.33 11/30/202317,420,000 shares $1.33 billion -3.9%N/A3 $76.60Elon’s BIGGEST warning yet? (Ad)Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.Click here to see why Tesla's about to prove everyone wrong... again. 11/15/202318,130,000 shares $1.36 billion -7.0%N/A3.3 $75.04 10/31/202319,500,000 shares $1.53 billion -4.2%1.6%3.6 $78.54 10/15/202320,350,000 shares $1.58 billion +0.5%1.6%3.9 $77.65 9/30/202320,240,000 shares $1.52 billion +10.4%1.6%3.8 $74.94 9/15/202318,330,000 shares $1.39 billion +0.4%1.5%3.3 $75.67 8/31/202318,250,000 shares $1.40 billion -7.0%1.5%3.2 $76.48 8/15/202319,630,000 shares $1.56 billion +4.2%1.6%3.4 $79.64 7/31/202318,840,000 shares $1.43 billion +7.2%N/A3.3 $76.14 7/15/202317,570,000 shares $1.36 billion +1.3%N/A3 $77.19 6/30/202317,340,000 shares $1.34 billion +6.3%N/A3.2 $77.07 6/15/202316,320,000 shares $1.29 billion +6.8%N/A3 $79.00 5/31/202315,280,000 shares $1.18 billion -15.0%N/A2.7 $76.94 5/15/202317,980,000 shares $1.41 billion -6.7%N/A3.4 $78.38 4/30/202319,280,000 shares $1.59 billion +26.4%N/A3.4 $82.21 4/15/202315,250,000 shares $1.27 billion -1.5%N/A2.6 $83.00 3/31/202315,480,000 shares $1.28 billion +1.8%N/A2.6 $82.97 3/15/202315,200,000 shares $1.21 billion -2.9%N/A2.5 $79.65 2/28/202315,660,000 shares $1.26 billion -0.6%N/A2.3 $80.53 2/15/202315,760,000 shares $1.34 billion +3.9%N/A2.3 $85.05 1/31/202315,170,000 shares $1.27 billion +1.6%N/A2.1 $83.94 1/15/202314,930,000 shares $1.29 billion -8.0%N/A1.9 $86.27 12/30/202216,220,000 shares $1.39 billion +9.9%N/A2.1 $85.85 12/15/202214,760,000 shares $1.28 billion -16.0%N/A1.8 $86.58 11/30/202217,560,000 shares $1.54 billion -15.3%N/A2.1 $87.83 11/15/202220,730,000 shares $1.72 billion +8.7%N/A2.5 $83.00 10/31/202219,070,000 shares $1.50 billion +15.8%N/A2.4 $78.46 10/15/202216,470,000 shares $1.09 billion +0.1%N/A2.3 $66.17 9/30/202216,450,000 shares $1.01 billion -1.4%N/A2.4 $61.69 9/15/202216,690,000 shares $1.08 billion -0.5%N/A2.5 $65.00 8/31/202216,770,000 shares $1.06 billion -1.6%N/A2.5 $63.47 8/15/202217,040,000 shares $1.13 billion +20.3%N/A2.5 $66.21 7/31/202214,160,000 shares $846.06 million -14.5%N/A2 $59.75 7/15/202216,560,000 shares $1.04 billion +13.0%N/A2.2 $62.60 6/30/202214,650,000 shares $905.52 million -6.4%N/A1.9 $61.81 6/15/202215,650,000 shares $913.80 million +6.6%N/A1.9 $58.39 5/31/202214,680,000 shares $952.00 million -12.9%N/A1.7 $64.85 5/15/202216,850,000 shares $1.05 billion +0.9%N/A1.7 $62.37 4/30/202216,700,000 shares $990.98 million +8.7%N/A1.6 $59.34 4/15/202215,370,000 shares $950.17 million +6.3%N/A1.4 $61.82 3/31/202214,460,000 shares $859.65 million -2.6%N/A1.3 $59.45 3/15/202214,840,000 shares $865.47 million -20.3%N/A1.4 $58.32 2/28/202218,630,000 shares $1.13 billion -16.2%N/A1.9 $60.40 2/15/202222,240,000 shares $1.36 billion -7.9%N/A2.3 $61.33 1/31/202224,150,000 shares $1.66 billion +10.4%N/A2.9 $68.68 1/15/202221,880,000 shares $1.57 billion +2.7%N/A0 $71.77 12/31/202121,300,000 shares $1.55 billion -4.1%N/A3 $72.61 12/15/202122,200,000 shares $1.58 billion +1.4%N/A3.2 $71.21 11/30/202121,890,000 shares $1.51 billion -5.3%N/A3.2 $68.93 11/15/202123,120,000 shares $1.55 billion +5.5%N/A3.5 $67.20 10/29/202121,920,000 shares $1.42 billion -8.7%N/A3.4 $64.88Elon’s BIGGEST warning yet? (Ad)Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.Click here to see why Tesla's about to prove everyone wrong... again. 10/15/202124,010,000 shares $1.62 billion -1.1%N/A3.8 $67.63 9/30/202124,280,000 shares $1.70 billion +16.2%N/A3.9 $69.85 9/15/202120,900,000 shares $1.50 billion -6.9%N/A3.4 $71.76 8/31/202122,450,000 shares $1.63 billion -12.7%N/A3.7 $72.78 8/13/202125,700,000 shares $1.83 billion -0.1%N/A4.1 $71.16 7/30/202125,730,000 shares $1.76 billion -5.5%N/A4 $68.29 7/15/202127,220,000 shares $1.86 billion +12.3%N/A4.1 $68.30 6/30/202124,230,000 shares $1.67 billion +0.9%N/A3.5 $68.86 6/15/202124,020,000 shares $1.64 billion +1.4%N/A3.4 $68.09 5/28/202123,690,000 shares $1.57 billion -7.9%N/A3.2 $66.11 5/14/202125,720,000 shares $1.77 billion -10.2%2.1%3.3 $68.91 4/30/202128,640,000 shares $1.83 billion +10.1%2.3%3.7 $63.84 4/15/202126,010,000 shares $1.70 billion +11.0%2.1%3.4 $65.30 3/31/202123,440,000 shares $1.54 billion +4.1%1.9%2.8 $65.50 3/15/202122,520,000 shares $1.39 billion -5.5%1.8%2.4 $61.56 2/26/202123,830,000 shares $1.50 billion +3.1%1.9%2.6 $62.79 2/12/202123,110,000 shares $1.55 billion +7.1%1.9%2.6 $66.92 1/29/202121,580,000 shares $1.40 billion -3.5%1.7%2.3 $64.68 1/15/202122,370,000 shares $1.40 billion +3.7%1.8%2.3 $62.40 12/31/202021,570,000 shares $1.22 billion +22.1%1.7%2.2 $56.65 12/15/202017,670,000 shares $1.06 billion -14.8%1.4%1.9 $59.84 11/30/202020,730,000 shares $1.24 billion -4.5%1.7%2.2 $60.03 11/15/202021,710,000 shares $1.32 billion -4.4%1.7%2.3 $60.59 10/30/202022,700,000 shares $1.33 billion +10.7%1.8%2.4 $58.53 10/15/202020,500,000 shares $1.31 billion +5.9%1.6%2.1 $64.05 9/30/202019,360,000 shares $1.22 billion +7.9%1.6%2.2 $63.19 9/15/202017,950,000 shares $1.19 billion +11.0%1.4%2.1 $66.20 8/31/202016,170,000 shares $1.08 billion -14.1%1.3%1.9 $66.75 8/14/202018,830,000 shares $1.29 billion -11.7%1.5%2 $68.50 GILD Short Interest - Frequently Asked Questions What is Gilead Sciences' current short interest? Short interest is the volume of Gilead Sciences shares that have been sold short but have not yet been covered or closed out. As of July 15th, traders have sold 22,540,000 shares of GILD short. 1.82% of Gilead Sciences' shares are currently sold short. Learn More on Gilead Sciences' current short interest. What is a good short interest ratio for Gilead Sciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GILD shares currently have a short interest ratio of 3.0. Learn More on Gilead Sciences's short interest ratio. Which institutional investors are shorting Gilead Sciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Gilead Sciences: Mirae Asset Securities USA Inc., Simplex Trading LLC, Bank of New York Mellon Corp, Bank of Montreal Can, Allianz Asset Management GmbH, Twin Tree Management LP, Quaker Wealth Management LLC, Jane Street Group LLC, Parallax Volatility Advisers L.P., Millennium Management LLC, Cubist Systematic Strategies LLC, Caption Management LLC, Nomura Holdings Inc., BNP Paribas Financial Markets, Eisler Capital Management Ltd., PEAK6 LLC, Jane Street Group LLC, Walleye Trading LLC, Walleye Capital LLC, Capital Fund Management S.A., Hsbc Holdings PLC, Arrowpoint Investment Partners Singapore Pte. Ltd., Simplex Trading LLC, JPMorgan Chase & Co., and Citigroup Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Gilead Sciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.82% of Gilead Sciences' floating shares are currently sold short. Is Gilead Sciences' short interest increasing or decreasing? Gilead Sciences saw a increase in short interest in the month of July. As of July 15th, there was short interest totaling 22,540,000 shares, an increase of 7.4% from the previous total of 20,990,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Gilead Sciences' float size? Gilead Sciences currently has issued a total of 1,243,930,000 shares. Some of Gilead Sciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Gilead Sciences currently has a public float of 1,240,000,000 shares. How does Gilead Sciences' short interest compare to its competitors? 1.82% of Gilead Sciences' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Gilead Sciences: Ligand Pharmaceuticals Incorporated (6.38%), Moderna, Inc. (19.34%), Regeneron Pharmaceuticals, Inc. (1.99%), Vir Biotechnology, Inc. (12.67%), Vertex Pharmaceuticals Incorporated (1.64%), AbbVie Inc. (0.89%), Merck & Co., Inc. (1.15%), Pfizer Inc. (1.75%), Amgen Inc. (2.74%), Alnylam Pharmaceuticals, Inc. (2.58%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Gilead Sciences stock? Short selling GILD is an investing strategy that aims to generate trading profit from Gilead Sciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Gilead Sciences? A short squeeze for Gilead Sciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GILD, which in turn drives the price of the stock up even further. How often is Gilead Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GILD, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies LGND Short Interest MRNA Short Interest REGN Short Interest VIR Short Interest VRTX Short Interest ABBV Short Interest MRK Short Interest PFE Short Interest AMGN Short Interest ALNY Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GILD) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gilead Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gilead Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GILD Stock Alerts